Edition:
India

Sientra Inc (SIEN.OQ)

SIEN.OQ on NASDAQ Stock Exchange Global Select Market

19.93USD
20 Jul 2018
Change (% chg)

$0.19 (+0.96%)
Prev Close
$19.74
Open
$19.74
Day's High
$19.97
Day's Low
$19.64
Volume
91,318
Avg. Vol
164,004
52-wk High
$21.30
52-wk Low
$8.79

Latest Key Developments (Source: Significant Developments)

Sientra Receives FDA Approval Of PMA Supplement
Thursday, 19 Apr 2018 

April 18 (Reuters) - Sientra Inc ::SIENTRA RECEIVES FDA APPROVAL OF PMA SUPPLEMENT.SIENTRA INC - ADDITIONAL $10 MILLION OF EXISTING CREDIT FACILITY NOW ACCESSIBLE WITH FDA APPROVAL.SIENTRA INC - COMMERCIAL SALE OF U.S.-MANUFACTURED OPUS BRANDED BREAST IMPLANTS TO BEGIN IMMEDIATELY.  Full Article

Sientra Says Reached An Agreement-In-Principle With Staff Of Division Of Enforcement Of U.S. SEC
Tuesday, 27 Mar 2018 

March 26 (Reuters) - Sientra Inc ::SIENTRA INC - REACHED AN AGREEMENT-IN-PRINCIPLE WITH STAFF OF DIVISION OF ENFORCEMENT OF U.S. SECURITIES AND EXCHANGE COMMISSION - SEC FILING.SIENTRA - THERE IS NO MONETARY COMPONENT TO AGREEMENT-IN-PRINCIPLE, BUT IT WILL CONTAIN ORDER PROHIBITING FUTURE VIOLATIONS OF SECURITIES LAWS.SIENTRA INC - AGREEMENT-IN-PRINCIPLE TO SETTLE SEC'S INVESTIGATION RELATED TO CO'S FOLLOW-ON PUBLIC OFFERING THAT CLOSED ON SEPT. 23, 2015.SIENTRA - TO CO'S KNOWLEDGE, SEC DOES NOT INTEND TO CHARGE ANY OF CO'S CURRENT OFFICERS OR DIRECTORS RELATED TO INVESTIGATION.  Full Article

Sientra Provides Update On FDA Review Of U.S. Manufacturing Facility
Wednesday, 31 Jan 2018 

Jan 30 (Reuters) - Sientra Inc ::SIENTRA® PROVIDES UPDATE ON FDA REVIEW OF U.S. MANUFACTURING FACILITY.SIENTRA INC - ‍FDA GRANTED APPROVAL OF SITE-CHANGE PMA SUPPLEMENT FOR CONTRACT MANUFACTURER TO MANUFACTURE CO'S SILICONE GEL BREAST IMPLANTS​.  Full Article

Sientra Announces Preliminary Unaudited Q4 Revenue
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Sientra Inc ::SIENTRA ANNOUNCES PRELIMINARY UNAUDITED FOURTH QUARTER 2017 REVENUE.SEES Q4 2017 REVENUE ABOUT $11.4 MILLION.Q4 REVENUE VIEW $11.8 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Sientra Inc Files For Mixed Shelf Of Upto $150 Million
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Sientra Inc ::SIENTRA INC FILES FOR MIXED SHELF OF UPTO $150 MILLION - SEC FILING.  Full Article

Sientra posts qtrly loss of $0.74​ per share
Wednesday, 8 Nov 2017 

Nov 7 (Reuters) - Sientra Inc :Sientra reports third quarter 2017 financial results.Total net sales for Q3 2017 were $9.8 million, compared to total net sales of $6.5 million for same period in 2016​.Qtrly ‍basic and diluted net loss per share attributable to common stockholders $0.74​.Net cash and cash equivalents as of September 30, 2017 were $37.6 million compared to $55.5 million at end of Q2 2017​.  Full Article

Sientra Q2 loss per share $0.56
Tuesday, 9 Aug 2016 

Sientra Inc : Q2 sales $6.2 million versus $14.2 million . sientra® reports second quarter 2016 financial results and progress on manufacturing solution .Qtrly loss per share $0.56.  Full Article

Sientra updates on manufacturing solution
Tuesday, 9 Aug 2016 

Sientra Inc : Sientra provides update on manufacturing solution . Vesta establishing manufacturing capacity for sientra,working with co to finalize supply arrangement for pma-approved breast implants . Entered into a services agreement with Vesta, a lubrizol lifesciences company .Anticipates that all project milestones will be achieved for company to submit a pma supplement to fda during q1 of 2017.  Full Article

BRIEF-Sientra Q1 Loss Per Share $0.99

* Q1 EARNINGS PER SHARE VIEW $-0.84 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: